Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)

  title={Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)},
  author={G-S Wang and K Y Yang and R Perng},
  journal={British Journal of Cancer},
  pages={1247 - 1250}
4 patients with advanced non-small-cell lung cancer (NSCLC) treated with docetaxel developed life-threatening pneumonitis requiring mechanical ventilation. Docetaxel (30–60 mg m–2, according to a different protocol) was infused within one hour with standard premedications. One patient’s pneumonitis occurred 5 days after the first dose of docetaxel, and that of the other 3 between the 2nd and 6th cycles. Based on the clinical course, radiological findings of an interstitial pneumonitis, and… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 29 extracted citations


Publications referenced by this paper.
Showing 1-10 of 23 references

Phase II trial of docetaxel in previously untreated advanced nonsmall-cell lung cancer: A Japanese cooperative study

  • H Kunitah, K Watanabe, T Onoshi, K Furuse, H Niitani, T Taguchi
  • J Clin Oncol
  • 1996
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…